Trial intelligence / Profile preview

Quercetin for Chemotherapy Induced Oral Mucositis

NCT01732393Phase 2Completed

Sponsor
Mashhad University of Medical Sciences
Start
Jan 2010
Primary completion
Oct 2011
Modality
Allosteric Modulators, Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in oral mucositis (OM) comparing Quercetin with Placebo (2 arms). Primary endpoint: lower grade of mucositis at 3 weeks. Started Jan 2010; status: completed.

02

Drugs

quercetin
03

Conditions

oral mucositis (OM)

Beyond the preview

Go deeper on NCT01732393.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01732393.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call